EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Insights into the interactions between ibuprofen arginine salt and parenteral nutrition: Assessment methods and potential risks

Katarzyna Dettlaff, Marta Klimaszewska, Katarzyna Dominiak, Aleksandra Kowalska, Julia Bartkiewicz, Maciej Stawny

Nutrition · 2025

DOI: 10.1016/j.nut.2025.112887 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, 2025. Verfasst von Katarzyna Dettlaff und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, Poznan, Poland. Electronic address: dettlaff@ump.edu.pl. Hauptthemen laut MEDLINE: Arginine, Ibuprofen, Parenteral Nutrition, Parenteral Nutrition Solutions. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Poznan University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: In the past decade, ibuprofen (IBF) infusion solutions with concentrations of 4 mg/mL and 6 mg/mL have been introduced into the pharmaceutical market. Due to the poor water solubility of IBF, these formulations incorporate arginine as an excipient, enabling the formation of a soluble salt known as IBF arginate. This study investigated the compatibility of IBF formulations with five commercially available parenteral nutrition (PN) multi-chamber bag mixtures. METHODS: IBF and PN were combined in proportions based on the administration rates recommended by the manufacturers for both the drug and the PN multi-chamber bag. The compatibility of IBF + PN was evaluated through visual inspection, pH and osmolality measurements, particle size analysis, polydispersity assessment, and zeta potential analysis. Additionally, the PFAT5 parameter was determined. To measure turbidity, lipid-free PN solutions were prepared by substituting the volume of the lipid emulsion with water for injections. All evaluations were conducted immediately after mixing the drug with the PN and again after 4 hours of storage. RESULTS: The IBF + PN samples formed a white emulsion without visible signs of destabilization or sediment. The pH of the IBF + PN samples ranged from 6.0 to 6.9, and the osmolality ranged from 457 to 1054 mOsm/kg. After 4 hours, the pH changes did not exceed 0.1 pH units, and the osmolality changes were within 3%. The mean particle size of the lipid emulsion ranged from 222 to 375 nm. In six cases, a second particle fraction with a size exceeding 4 µm was observed after 4 hours of storage. The PFAT5 parameter of all samples remained within 0.002% to 0.025% throughout the experiment. The turbidity of all IBF samples mixed with lipid-free PN ranged from 0.9 to 939 NTU, with the exception of IBF samples combined with the lipid-free, electrolyte-free PN model, which exhibited turbidity levels of ≤0.302 NTU. CONCLUSIONS: Administering IBF solutions through a single infusion line with PN poses a risk to patient safety as it, in many cases, causes sediment formation. These interactions between IBF and PN electrolytes may not be detectable by visual inspection alone, highlighting the importance of turbidimetric analysis of lipid-free PN + drug combinations as a critical component of drug-PN compatibility assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArginineIbuprofenParenteral NutritionParenteral Nutrition SolutionsHydrogen-Ion ConcentrationOsmolar ConcentrationParticle SizeExcipientsHumansSolubilityDrug Interactions

Stichwörter der Autor:innen

Drug compatibilityIbuprofenIntravenous administrationParenteral nutritionTurbidity

Substanzen

ArginineIbuprofenExcipientsParenteral Nutrition Solutions

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, Poznan, Poland. Electronic address: dettlaff@ump.edu.pl.
  • Scientific Society of Poznan University of Medical Sciences, Section "Drug and Cosmetic Analysis", Poznan, Poland.
  • Scientific Society of Poznan University of Medical Sciences, Section "Drug and Cosmetic Analysis", Poznan, Poland; Doctoral School, Poznan University of Medical Sciences, Poznan, Poland.
  • Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, Poznan, Poland.

Förderung

  • Poznan University of Medical Sciences

Zitieren

APA

Dettlaff, K., Klimaszewska, M., Dominiak, K., Kowalska, A., Bartkiewicz, J., & Stawny, M. (2025). Insights into the interactions between ibuprofen arginine salt and parenteral nutrition: Assessment methods and potential risks. Nutrition. https://doi.org/10.1016/j.nut.2025.112887

Vancouver

Dettlaff K, Klimaszewska M, Dominiak K, Kowalska A, Bartkiewicz J, Stawny M. Insights into the interactions between ibuprofen arginine salt and parenteral nutrition: Assessment methods and potential risks. Nutrition. 2025. doi:10.1016/j.nut.2025.112887

BibTeX
@article{Dettlaff2025,
  author = {Dettlaff, Katarzyna and Klimaszewska, Marta and Dominiak, Katarzyna and Kowalska, Aleksandra and Bartkiewicz, Julia and Stawny, Maciej},
  title = {Insights into the interactions between ibuprofen arginine salt and parenteral nutrition: Assessment methods and potential risks},
  journal = {Nutrition},
  year = {2025},
  doi = {10.1016/j.nut.2025.112887}
}
Kostenlos starten →